Pulmonx (LUNG) Long-Term Investments (2021 - 2024)

Pulmonx (LUNG) has 4 years of Long-Term Investments data on file, last reported at $4.3 million in Q1 2024.

• Long-Term Investments for Q1 2024 came in at $4.3 million, up 62.8% year-over-year; the trailing twelve-month figure through Mar 2024 was $4.3 million (up 62.8% YoY), and the FY2023 annual result was $14.4 million, up 142.91% from the prior year.
• Long-Term Investments eased to $4.3 million in Q1 2024 per LUNG's latest filing, from $14.4 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $23.3 million in Q3 2023 and troughed at $2.0 million in Q2 2021.
• A 4-year average of $7.7 million and a median of $5.3 million in 2022 frame the typical range for Long-Term Investments.
• On a YoY basis, Long-Term Investments climbed as much as 165.88% in 2023 and fell as far as 58.66% in 2023.
• A 4-year view of Long-Term Investments shows it stood at $10.9 million in 2021, then plunged by 45.86% to $5.9 million in 2022, then jumped by 142.91% to $14.4 million in 2023, then tumbled by 70.17% to $4.3 million in 2024.
• Business Quant data shows LUNG's Long-Term Investments at $4.3 million in Q1 2024, $14.4 million in Q4 2023, and $23.3 million in Q3 2023.